Keywords: Herceptin; Tukysa; Xeloda; adverse effects; cancer; capecitabine; colorectal; dosage; drug interactions; efficacy; fluoropyrimidine; irinotecan; lactation; oxaliplatin; pregnancy; safety; trastuzumab; tucatinib.